Search List of Extended Use Dates to Assist with Drug Shortages
Based on stability data provided by the manufacturers and reviewed by FDA, the following extended use dates are supported for specific lot numbers indicated in the searchable table below. Providers and patients that have the lot numbers in stock will be able to use them through the corresponding new use dates to help with supply. As data become available, this list can continue to expand.
FDA is not requiring or recommending that the identified lot numbers in the following table be relabeled with their new use dates. However, if replacement product becomes available during the extension period, then the agency expects the lots in these tables will be replaced and properly disposed of as soon as possible.
Please contact CDER Drug Shortage Staff at drugshortages@fda.hhs.gov with questions regarding this table.
| Product | Company | NDC Number | Lot Number | Expiration Date (Labeled) | Extended Use Date |
|---|---|---|---|---|---|
| Meperidine hydrochloride injection, 50 mg/mL, single dose cartridge with luer-lock, carton of 10 | Hospira, a Pfizer company | 0409-1178-30 | HN8657 | 30-Sep-2025 | 30-Jan-2026 |
| Ethiodized oil injection, 480 mg Iodine/mL, single dose vial | Guerbet | 67684-1901-2 | 24LF701A | 31-Dec-2025 | 31-Mar-2026 |
| Dantrolene sodium for injectable suspension, 250 mg, single-dose vial | Eagle Pharmaceuticals, Inc. | 42367-540-32 | B235030 | 30-Sep-2025 | 30-Jun-2026 |
| Dantrolene sodium for injectable suspension, 250 mg, single-dose vial | Eagle Pharmaceuticals, Inc. | 42367-540-32 | B235034 | 31-Oct-2025 | 31-Jul-2026 |